Trovagene, Inc. TROV Income Statement

Trovagene, inc. (TROV)

Income statement / TTM

Mar'20	Dec'19	Sep'19	Jun'19	Mar'19	Dec'18	Sep'18	Jun'18	Mar'18	Dec'17	Sep'17	Jun'17	Mar'17	Dec'16	Sep'16	Jun'16	Mar'16	Dec'15	Sep'15	Jun'15	Mar'15	Dec'14	Sep'14	Jun'14	Mar'14	Sep'13	Jun'13	Dec'11	Sep'11	Jun'11	Mar'11
Revenues [Abstract]
Royalties
0	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total revenues
250	244	340	400	0	-	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Royalties
-	-	-	-	-	-	-	-	268	285	219	208	211	258	259	263	262	274	279	285	284	270	257	249	0	0	0	227	0	0	0
License fees
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	-	-	-	-	-	-	-
Services and other
-	-	-	-	-	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Diagnostic services
-	-	-	-	-	-	-	-	-	-	159	138	107	86	0	0	0	-	0	0	0	-	0	-	-	-	-	-	-	-	-
Clinical research services
-	-	-	-	-	-	-	-	-	-	9	7	37	36	0	0	0	-	0	0	-	-	-	-	-	-	-	-	-	-	-
Total revenues
-	-	-	-	-	-	-	-	510	505	388	354	355	381	392	360	306	312	290	289	296	280	267	259	0	0	0	257	0	0	0
Costs and expenses:
Cost of revenue
-	-	0	26	-	597	981	1,427	1,561	1,811	2,015	1,966	2,037	1,730	1,342	1,091	762	629	429	0	0	-	0	-	-	-	-	-	-	-	-
Research and development
11,219	11,162	10,794	9,806	8,928	8,164	6,873	6,457	5,486	7,882	10,461	12,983	16,078	15,006	14,387	12,996	11,604	10,593	9,263	8,707	7,420	6,664	5,745	4,699	0	0	0	910	0	0	0
Selling and marketing
-	-	-	-	-	-	-	-	-	-	-	-	-	11,523	11,062	9,919	8,706	6,443	5,543	4,286	2,959	2,734	2,030	1,955	0	0	0	-	-	-	-
Selling, general and administrative
5,871	5,760	6,027	6,252	6,875	8,005	8,195	10,609	13,133	14,232	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
General and administrative
-	-	-	-	-	-	-	-	-	-	-	-	-	11,475	11,347	10,585	10,118	7,919	7,430	6,948	6,257	5,810	6,010	5,558	0	0	0	-	0	0	0
Restructuring charges
-	-	0	0	-	-	0	0	-	2,174	2,459	2,506	2,510	790	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total operating expenses
17,091	16,923	16,822	16,507	16,700	17,431	17,219	19,196	20,635	26,101	31,982	36,074	40,168	40,526	38,139	34,592	31,190	25,586	22,683	20,213	16,829	15,225	0	0	0	-	-	-	-	-	-
Total operating expenses
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	3,234	0	0	0
Loss from operations
-16,840	-16,678	-16,492	-16,140	-16,360	-17,053	-16,734	-18,676	-20,125	-25,595	-31,593	-35,720	-39,812	-40,145	-37,747	-34,232	-30,884	-25,273	-22,393	-19,923	-16,533	-14,945	-13,519	-11,953	0	0	0	-2,976	0	0	0
Interest income
0	-	0	0	0	-	0	0	0	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Interest income
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	7	0	0	0	-	0	0	0	0
Interest expense
-	-	0	0	-	25	0	0	0	-	0	-	-	-	-	-	-	-	-	-	-	-	460	71	0	0	0	56	0	0	0
Gain on extinguishment of debt
-	-	0	0	-	-	0	0	-	-	0	0	-	-	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net interest income (expense)
-	-	-	-	-	-	-	-	-	-	-	0	0	-	-1,335	-1,316	-1,422	-1,468	0	0	0	-	-	-	-	-	-	-	-	-	-
Gain on disposal of equipment
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	-	-	-
Gain (loss) from change in fair value of derivative financial instruments—warrants
40	28	65	49	737	617	1,967	3,498	2,715	3,401	3,800	2,359	2,483	2,462	1,053	4,982	1,754	-726	-900	-5,946	-553	1,425	-96	-1,962	0	0	0	170	0	0	0
Other income (expense), net
0	-	0	0	0	-	0	0	0	-	0	0	0	-	0	0	-	-	0	0	0	-	0	-	-	-	-	-	-	-	-
Net loss
-16,597	-16,414	-16,330	-15,958	-15,579	-16,461	-14,872	-15,394	-19,693	-24,906	-30,884	-36,784	-38,940	-39,203	-38,036	-30,581	-30,559	-27,471	-24,773	-27,413	-18,310	-14,325	-14,043	-13,938	0	0	0	-2,239	0	0	0
Preferred stock dividend payable on Series A Convertible Preferred Stock
24	24	24	24	24	24	24	24	24	24	24	24	24	24	24	24	24	24	24	24	19	23	22	25	0	0	0	38	0	0	0
Deemed dividend recognized for beneficial conversion features of Convertible Preferred Stock issuance
0	-	-	-	0	-	-	-	0	-	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net loss attributable to common stockholders
-16,622	-16,706	-16,622	-16,250	-18,641	-19,254	-17,665	-18,188	-19,717	-24,930	-30,909	-36,808	-38,964	-39,227	-38,061	-30,605	-30,583	-27,495	-24,797	-27,437	-18,329	-14,348	-14,065	-13,963	0	0	0	-2,277	0	0	0
Net loss per common share - basic (in USD per share)
-	-	-0.71	-0.79	-	-	-1.10	-5.27	-6.23	-43.35	-1.41	-3.12	-3.88	-14.57	-0.34	-0.34	-0.35	-0.21	-0.10	-0.41	-0.33	-0.25	-0.28	-0.06	-0.17	-	-	-	-	-	-
Net loss per common share - diluted (in USD per share)
-	-	-0.71	-0.79	-	-	-1.10	-5.27	-6.23	-43.35	-1.41	-3.12	-3.88	-14.51	-0.34	-0.34	-0.36	-0.24	-0.23	-0.41	-0.33	-0.26	-0.28	-0.17	-0.17	-	-	-	-	-	-
Weighted Average Number of Shares Outstanding, Basic
-	-	5,822	5,241	-	-	3,437	1,237	768	-6,274	3,038	2,582	2,580	-79,994	30,339	29,958	29,755	29,836	28,560	24,592	21,817	18,908	18,902	18,902	18,902	-	-	-	-	-	54,137
Weighted Average Number of Shares Outstanding, Diluted
-	-	5,822	5,241	-	-	3,437	1,237	768	-6,274	3,038	2,582	2,580	-80,312	30,339	29,958	30,108	30,269	29,128	24,592	21,817	19,246	18,902	19,232	18,902	-	-	-	-	-	54,137
Net loss per common share - basic and diluted (in dollars per share)
-0.41	-	-	-	-1.02	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-0.25	-0.34	-0.12	0.00	-0.10	-0.01
Weighted-average shares outstanding - basic and diluted (in shares)
9,910	-	-	-	4,086	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	17,870	15,583	-	-	-	-
Royalties
Royalties
-	-	0	0	-	-	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Services
Services
-	-	0	0	-	-	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Series B Convertible Preferred Stock
Deemed dividend recognized on beneficial conversion features of Convertible Preferred Stock issuance
-	-	0	0	-	-	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Series C Convertible Preferred Stock
Deemed dividend recognized on beneficial conversion features of Convertible Preferred Stock issuance
-	-	0	0	-	-	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-